Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ST266 for UV-induced Inflammation
NCT02389777Phase 2Completed
- Sponsor
- Noveome Biotherapeutics
- Start
- Mar 2015
- Primary completion
- Aug 2015
- Modality
- Cytokines & Interferons, Hormones & Growth Factors
01
Overview
Phase 2, open-label trial of ST266 in sunburn (3 arms), sponsored by Noveome Biotherapeutics. Primary endpoint: Erythema resolution at 3 days. Started Mar 2015; status: completed.
02
Drugs
ST266
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT02389777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02389777.